0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Eric K. Nakakura, MD, PhD
JAMA Surg. 2014;149(5):466. doi:10.1001/jamasurg.2013.5282.

Original Investigation | 
Raymond F. Lamore III, PharmD; Elizabeth M. Hechenbleikner, MD; Christina Ha, MD; et al.
JAMA Surg. 2014;149(5):459-466. doi:10.1001/jamasurg.2013.5278.
Sign in to download this free article PDF

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Viewpoint  | 
Mandatory Use of Prescription Drug Monitoring Programs
Rebecca L. Haffajee, JD, MPH; Anupam B. Jena, MD, PhD; Scott G. Weiner, MD, MPH
JAMA Internal Medicine
Teachable Moment  | 
Sense and Nonsense of Treatment of Comorbid Diseases in Terminally Ill Patients
Eric C. T. Geijteman, MD; Teun van Gelder, MD, PhD; Lia van Zuylen, MD, PhD
JAMA Psychiatry
Viewpoint  | 
Retaining Part D’s Comprehensive Coverage of Antidepressants:  Not a Silver Bullet
Yuhua Bao, PhD; Yan Tang, MS; Julie Donohue, PhD
JAMA Internal Medicine
Research Letter  | 
Orders for Intravenous Proton Pump Inhibitors After Implementation of an Electronic Alert
Daniel E. Freedberg, MD, MS; Hojjat Salmasian, MD, MPH; Julian A. Abrams, MD, MS; et al.